Relationship between inappropriate left ventricular hypertrophy and ejection fraction independent of absolute or indexed mass in a community sample of black African ancestry

Journal of Hypertension

Volumn 31, Issue 1, 2013, Pages 169-176

  Libhaber, Carlos D ^a,b   Norton, Gavin R ^a   Maseko, Muzi J ^a   Majane, Olebogeng H I ^a   Millen, Aletta M E ^a   Maunganidze, Fabian ^a   Michel, Frederic S ^a   Brooksbank, Richard ^a   Libhaber, Elena ^b   Sareli, Pinhas ^a   Woodiwiss, Angela J ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

ejection fraction; left ventricular hypertrophy; left ventricular systolic function

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART STROKE VOLUME; HEART WORK; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

EID: 84871720166     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835a8696     Document Type: Article

References (38)

1. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographic measurement of left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
3. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117:831-836.
4. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-1562.
5. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35:1628-1637.
6. Gardin JM, McClellan R, Kitzman D, Lima JAC, Bommer W, Klopfenstein HS, et al. M-mode echocardiographic predictors of six-to-seven year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort. Am J Cardiol 2001; 87:1051-1057.
7. Aurigemma G, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2001; 37:1042-1048.
8. Drazner MH, Rame JE, Marino EK, Gottdiener JS, Kitzman DW, Gardin JM, et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol 2004; 43:2207-2215.
9. Drazner MH. The progression of hypertensive heart disease. Circulation 2011; 123:327-334.
10. Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghof E, Gardin JM, Arynchyn A, et al. Racial differences in incident heart failure among young adults. N Engl J Med 2009; 360:1179-1190.
11. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite a depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995; 26:195-202.
12. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451.
13. Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991; 83:1676-1684.
14. Perlini S, Muiesan ML, Cuspidi C, Sampieri L, Trimarco B, Aurigemma GP, et al. Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. Circulation 2001; 103:678-683.
15. Hartford M, Wikstrand JC, Wallentin I, Ljungman SM, Berglund GL. Left ventricular wall stress and systolic function in untreated primary hypertension. Hypertension 1985; 7:97-104.
16. Wachtell K, Palmieri V, Olsen MH, Gerdts E, Papademetriou V, Nieminen MS, et al. Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) study. Circulation 2002; 106:227-232.
17. de Simone G, Devereux RB, Kimball TR, Mureddu GF, Roman MJ, Contaldo F, et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998; 31:1077-1082.
18. Palmieri V, de Simone G, Roman MJ, Schwartz JE, Pickering TG, Devereux RB. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension 1999; 34:1032-1040.
19. Palmieri V, Wachtell K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, et al. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE Study. Am Heart J 2001; 141:784-791.
20. Celentano A, Palmieri V, Esposito NDP, Pietropaola I, Crivaro M, Mureddu GF, et al. Inappropriate left ventricular mass in normotensive and hypertensive patients. Am J Cardiol 2001; 87:361-363.
21. de Simone G, Kitzman DW, Palmieri V, Liu JE, Oberman A, Hopkins PN, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction. Am J Hypertens 2004; 17:828-833.
22. Chinali M, de Simone G, Roman MJ, Lee ET, Best LG, Howard BV, et al. Impact of obesity on cardiac geometry and function in a population of adolescents. J Am Coll Cardiol 2006; 47:2267-2273.
23. Chinali M, De Marco M, Daddeo G, Benincasa M, Romano C, Galderisi M, et al. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities. J Hypertens 2007; 25:1073-1078.
24. Cioffi G, Tarantini L, Frizzi R, Stefenelli C, Russo TE, Selmi A, et al. Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. J Hypertens 2011; 29:565-573.
25. Norton GR, Maseko M, Libhaber E, Libhaber CD, Majane OHI, Dessein P, et al. Is prehypertension an independent predictor of target organ changes in young-to-middle aged persons of African descent? J Hypertens 2008; 26:2279-2287.
26. Woodiwiss AJ, Molebatsi N, Maseko MJ, Libhaber E, Libhaber C, Majane OHI, et al. Nurse-recorded auscultatory blood pressure at a single visit predicts target organ changes as well as ambulatory blood pressure. J Hypertens 2009; 27:287-297.
27. Redelinghuys M, Norton GR, Scott L, Maseko MJ, Brooksbank R, Majane OHI, et al. Relationship between urinary salt excretion and pulse pressure and central aortic hemodynamics independent of steady state pressure in the general population. Hypertension 2010; 56:584-590.
28. Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for the detection of type 2 diabetes: a systematic review. Diabetes Med 2007; 24:333-343.
29. Libhaber CD, Norton GR, Majane OHI, Libhaber E, Essop MR, Brooksbank R, et al. Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity. Am J Cardiol 2009; 104:1527-1533.
30. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiograph assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
31. Nunez E, Arnett DK, Benjamin EJ, Liebson PR, Skelton TN, Taylor H, et al. Optimal threshold value for left ventricular hypertrophy in blacks in the Atherosclerosis Risk in Communities study. Hypertension 2005; 45:58-63.
32. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37:7-11.
33. de Simone G, Devereux RB, Ganau A, Hahn RT, Saba PS, Mureddu F, et al. Estimation of left ventricular chamber and stroke volume by limited M-Mode echocardiography and validation by two-dimensional and Doppler echocardiography. Am J Cardiol 1996; 78:801-807.
34. de Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI study. Hypertension 2002; 40:470-476.
35. Mureddu GF, Pasanisi F, Palmieri V, Celentano A, Contaldo F, de Simone G. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. J Hypertens 2001; 19:1113-1119.
36. Palmieri V, Wachtell K, Bella JN, Gerdts E, Papademetriou V, Nieminen MS, et al. Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study. J Hum Hypertens 2004; 18:423-430.
37. Mureddu GF, Cioffi G, Stefenelli C, Boccanelli A, de Simone G. Compensatory or inappropriate left ventricular mass in different models of left ventricular pressure overload: comparison between patients with aortic stenosis and arterial hypertension. J Hypertens 2009; 27:642-649.
38. Woodiwiss AJ, Libhaber CD, Libhaber E, Sareli P, Norton GR. Relationship between on-treatment decreases in inappropriate versus absolute or indexed left ventricular mass and increases in ejection fraction in hypertension. Hypertension (in-press).